Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

GeneDx Holdings (WGSWW) Receivables - Other (2020 - 2023)

GeneDx Holdings has reported Receivables - Other over the past 4 years, most recently at $2.9 million for Q2 2023.

  • Quarterly results put Receivables - Other at $2.9 million for Q2 2023, down 33.53% from a year ago — trailing twelve months through Jun 2023 was $2.9 million (down 33.53% YoY), and the annual figure for FY2022 was $1.5 million, down 54.49%.
  • Receivables - Other for Q2 2023 was $2.9 million at GeneDx Holdings, up from $636000.0 in the prior quarter.
  • Over the last five years, Receivables - Other for WGSWW hit a ceiling of $4.4 million in Q2 2022 and a floor of $54000.0 in Q4 2021.
  • Median Receivables - Other over the past 4 years was $636000.0 (2023), compared with a mean of $1.7 million.
  • Biggest five-year swings in Receivables - Other: soared 2677.78% in 2022 and later crashed 83.04% in 2023.
  • GeneDx Holdings' Receivables - Other stood at $289000.0 in 2020, then tumbled by 81.31% to $54000.0 in 2021, then soared by 2677.78% to $1.5 million in 2022, then surged by 93.33% to $2.9 million in 2023.
  • The last three reported values for Receivables - Other were $2.9 million (Q2 2023), $636000.0 (Q1 2023), and $1.5 million (Q4 2022) per Business Quant data.